"As [Lululemon] continues to execute on bringing more newness into its assortment, we expect demand trends to continue to improve," Civello wrote, which combined with easier year-over-year comparisons ...
Shares of Moderna Inc. were plunging in early trading Monday, after the biotechnology company provided a downbeat revenue outlook and said it expects to burn more than $3 billion in cash in 2025.